By Debdeep Gupta | 15 Mar, 2024
Biocon stock falls 4?ter subsidiary sells branded formulations biz to Eris Lifesciences
Biocon Biologics said that it has entered into a long-term commercial collaboration with Eris Lifesciences to expand patient access to its portfolio of Metabolics, Oncology, and Critical Care products in India.Shares of Biocon fell over 4 percent on March 15 after its subsidiary Biocon Biologics' India-branded formulation business was acquired by Eris Lifesciences, a chronic therapy-focused drug f...
Live Comments
Anushmita1 2023-01-26 15:34:21
eris life Looking WEAK NOW, only buying above 632 if closes succesfully in hourly charts
Login & Reply Like(0) Dislike(0) Repost SpamDUDU 2022-08-05 12:25:25
results will be declared on Aug 5 along with interim dividend
Login & Reply Like(0) Dislike(0) Repost SpamSanchi_Bullish_India 2022-07-11 10:23:00
suttested to Buy Eris Lifesciences, target price Rs 850
Login & Reply Like(0) Dislike(0) Repost Spam